Malini B. DeSilva, MD, MPH
Research Investigator, MD
"Health disparities issues have been the foundation of both my clinical and research interests, in particular I have worked to address health challenges among vulnerable populations including non-English speaking persons. I attempt to promote health equity through my research by providing evidence needed support policy change."
About
Dr. Malini B. DeSilva is a Research Investigator and the Co-Director of the Pregnancy and Child Health Research Center at HealthPartners Institute. She is also an affiliated faculty at the University of Minnesota in the Department of Medicine’s Global Health Pathway and a practicing physician for both the HealthPartners Travel & Tropical Medicine Department and the St. Paul-Ramsey County Tuberculosis Clinic. She received her MD from Mayo Medical School and an MPH from the University of Minnesota School of Public Health. Dr. DeSilva completed her Med-Peds residency at the University of Minnesota and is double boarded in both internal medicine and pediatrics. Following residency, she completed the Centers for Disease Control and Prevention’s Epidemic Intelligence Service.

Dr. DeSilva’s current research focuses primarily on refugee and immigrant health and vaccine preventable diseases. Health disparities issues have been at the center of both her clinical and research interests, particularly focused on non-English speaking populations and addressing vaccine safety issues in pregnant persons. She is the lead HealthPartners investigator for two CDC funded research networks, the Center of Excellence in Newcomer Health and VISION (Virtual Network: Investigating the Risk of COVID-19-Associated Outcomes and COVID-19 Vaccine Effectiveness Using Integrated Medical and Public Health Records).

Other offices/titles: Staff physician, HealthPartners Department of Infectious Diseases and Travel and Tropical Medicine Center; staff physician, St. Paul-Ramsey County Tuberculosis Clinic

Joined the Institute: 2019

Education and training: MD, Mayo Medical School, Rochester, MN; MPH, University of Minnesota School of Public Health, Minneapolis; Certificate of Tropical Medicine, University of Minnesota, Minneapolis.

Overview/research interests: Refugee health, vaccine-preventable diseases, health disparities, and integration of public health and medicine.

Current research activities and funding:

  • Vaccine Safety DataLink
  • Effectiveness of Maternal Tdap Administration on Infant Pertussis Disease
  • Team-Based and Technology-Drive Adherence Intervention to Improve Chronic Disease Outcomes
  • Hotspotting Cardiometabolic Disparities for Simulated Advances in Population Care
  • The CENTER: Center of Excellence, a Network for Training and Epidemiology in Refugee Health
Affiliation
positions
  • Research Investigator, Vaccines
  • Research Investigator, Pregnancy and child health 2019 -
  • Publications
    selected publications
    Journal Article
  • Association of the COVID-19 pandemic with routine childhood vaccination rates and proportion up to date with vaccinations across 8 US health systems in the Vaccine Safety Datalink
    JAMA pediatrics. 2022
  • Cancer screening in refugees and immigrants: a global perspective
    American Journal of Tropical Medicine and Hygiene. 2022
  • Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic
    Vaccine. 2022
  • Effectiveness of BNT162b2 and mRNA-1273 second doses and boosters for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and SARS-CoV-2-related hospitalizations: a statewide report from the Minnesota Electronic Health Record Consortium
    Clinical Infectious Diseases. 2022
  • Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5-17 years - VISION Network, 10 states, April 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during oeriods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021
    American Journal of Transplantation. 2022
  • Evaluation of acute adverse events after Covid-19 vaccination during pregnancy
    New England Journal of Medicine. 2022
  • How to make up for rotavirus vaccination missed during the COVID-19 pandemic?-Reply
    JAMA pediatrics. 2022
  • Improving care for patients with chronic hepatitis B via establishment of a disease registry
    American Journal of Tropical Medicine and Hygiene. 2022
  • Minnesota Electronic Health Record Consortium COVID-19 Project: informing pandemic response through statewide collaboration using observational data
    Public Health Reports. 2022
  • Monitoring vaccine safety using the vaccine safety Datalink: assessing capacity to integrate data from Immunization Information systems
    Vaccine. 2022
  • Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, United States, December 15, 2020-July 22, 2021
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Travelers and travel vaccines at six health care systems in the Vaccine Safety Datalink
    Vaccine. 2022
  • Trends in COVID-19 vaccine administration and effectiveness through October 2021
    JAMA network open. 2022
  • Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Antimicrobial use in a cohort of US nursing homes, 2017
    JAMA. 2021
  • Association of inadvertent 9-valent human papillomavirus vaccine in pregnancy with spontaneous abortion and adverse birth outcomes
    JAMA network open. 2021
  • COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Developing algorithms for identifying major structural birth defects using automated electronic health data
    Pharmacoepidemiology and Drug Safety. 2021
  • Drug-dispensing limits within Medicaid during the COVID-19 pandemic
    Journal of managed care & specialty pharmacy. 2021
  • Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults - nine states, January-September 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings
    New England Journal of Medicine. 2021
  • Hepatitis B evaluation and linkage to care for newly arrived refugees: a multisite quality improvement initiative
    Journal of immigrant and minority health. 2021
  • Interim estimates of COVID-19 vaccine effectiveness against COVID-19-associated emergency department or urgent care clinic encounters and hospitalizations among adults during SARS-CoV-2 B.1.617.2 (Delta) variant predominance - nine states, June-August 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19-like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity - nine states, January-September 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Spontaneous abortion following COVID-19 vaccination during pregnancy
    JAMA. 2021
  • A best practice alert for identifying hepatitis B-infected patients
    American Journal of Tropical Medicine and Hygiene. 2020
  • Assessment of health care exposures and outcomes in adult patients with sepsis and septic shock
    JAMA network open. 2020
  • Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration - United States, 2020
    MMWR: Morbidity and Mortality Weekly Report. 2020
  • Epidemiology of antibiotic use for urinary tract infection in nursing home residents
    Journal of the American Medical Directors Association. 2020
  • Evaluation of a program to improve linkage to and retention in care among refugees with hepatitis B virus infection - three U.S. cities, 2006-2018
    MMWR: Morbidity and Mortality Weekly Report. 2020
  • Congenital microcephaly: case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation
    Vaccine. 2017
  • Maternal Tdap vaccination and risk of infant morbidity
    Vaccine. 2017
  • Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
    Vaccine. 2016
  • Tdap vaccination during pregnancy and microcephaly and other structural birth defects in offspring
    JAMA. 2016
  • Notes from the field: fatal yellow fever vaccine-associated viscerotropic disease--Oregon, September 2014
    MMWR: Morbidity and Mortality Weekly Report. 2015
  • Editorial Article
    Contact
    full name
  • Malini B. DeSilva, MD, MPH
  • primary email
  • Malini.B.DeSilva@HealthPartners.com
  • located in facility
    Quick Info
     
    Collaboration
    Contact Information More Info
    • Websites